Vertical Aerospace Ltd

Vertical Aerospace operates with a market capitalization of £342.5 million and a share price of £2.69, but its financial position shows significant cash outflows. The company reported negative operating cash flow of £19.4 million and free cash flow of £28.5 million in the latest period. With no balance-sheet inputs available, liquidity risk cannot be assessed, and there is no going-concern language in source documents to clarify the company's ability to continue operations. Profitability metrics are deeply negative, with operating income of £-20.9 million and net income of £-28.9 million, indicating substantial losses. These figures fall well below the industry median for aerospace and defense firms, which typically show positive operating margins and net income. The company's return on invested capital (ROIC) and other profitability ratios are not available, but the negative cash flows and losses suggest poor capital efficiency. The company's revenue is not disclosed in the latest financials, and no segment or geographic breakdown is available. This lack of transparency makes it difficult to assess revenue concentration or geographic exposure. Vertical Aerospace's business model is centered on eVTOL aircraft development, but the absence of revenue data prevents a detailed analysis of its market position or diversification. Looking ahead, Vertical Aerospace is expected to continue experiencing negative growth in the current fiscal year, with no clear path to profitability. The company has not provided specific revenue targets or growth projections for the next fiscal year, and its capital expenditure of £-343,000 suggests limited investment in new projects. The absence of revenue history and forward-looking guidance limits the ability to assess its growth trajectory. Risk factors include high liquidity risk due to negative cash flows and the absence of balance-sheet data. The company's dilution risk is currently low, but the lack of going-concern language and the absence of liquidity metrics suggest potential near-term financial stress. No dilution adjustments have been applied to the valuation, but the company's capital structure remains opaque. Recent events include analyst price targets ranging from £2.00 to £15.00, with a mean of £10.07 and a median of £11.00. The mean recommendation score of 2.12 indicates a generally positive outlook, with six "buy" ratings and one "strong buy" rating. No recent filings or transcripts have been provided to detail specific developments or strategic shifts.